<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Calcium toxicity remains the central focus of ischemic brain injury </plain></SENT>
<SENT sid="1" pm="."><plain>Calcium channel <z:chebi fb="68" ids="48706">antagonists</z:chebi> have been reported to be neuroprotective in ischemic animal models but have failed in clinical trials </plain></SENT>
<SENT sid="2" pm="."><plain>Rather than block the calcium channels, calbindin proteins can buffer excessive intracellular <z:chebi fb="0" ids="29108">Ca2+</z:chebi>, and as a result, maintain the calcium homeostasis </plain></SENT>
<SENT sid="3" pm="."><plain>In the present study, we investigated the effect of calbindin D 28k (CaBD) in ischemic brain using the novel technique protein transduction domain (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e>)-mediated protein transduction </plain></SENT>
<SENT sid="4" pm="."><plain>We generated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e>-CaBD in Escherichia coli, tested its biologic activity in <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> (<z:chebi fb="0" ids="31882">NMDA</z:chebi>)- and oxygen-<z:chebi fb="105" ids="17234">glucose</z:chebi> deprivation (OGD)-induced hippocampal injury models, and examined the protection of the fusion protein using a rat brain focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> model </plain></SENT>
<SENT sid="5" pm="."><plain><z:mpath ids='MPATH_124'>Infarct</z:mpath> volume was determined using 2,3,5-triphenyl-tetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> staining; neuronal injury was examined using terminal deoxynucleotidyl transferase-mediated <z:chebi fb="0" ids="16450">2'-deoxyuridine</z:chebi> 5'-<z:chebi fb="0" ids="15266,18036">triphosphate</z:chebi>-<z:chebi fb="1" ids="15956">biotin</z:chebi> nick end labeling (TUNEL) staining and cleaved caspase-3 assay </plain></SENT>
<SENT sid="6" pm="."><plain>The results showed that the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e>-CaBD was efficiently delivered into Cos7 cells, hippocampal slice cells, and brain tissue </plain></SENT>
<SENT sid="7" pm="."><plain>Pretreatment with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e>-CaBD decreased intracellular free calcium concentration and reduced cell <z:hpo ids='HP_0011420'>death</z:hpo> in <z:chebi fb="0" ids="31882">NMDA</z:chebi>- or OGD-exposed hippocampal slices (P&lt;0.05) </plain></SENT>
<SENT sid="8" pm="."><plain>Intraperitoneal administration of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e>-CaBD before transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> decreased brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume (280+/-47 versus 166+/-70 mm3, P&lt;0.05), and improved neurologic outcomes compared with the control </plain></SENT>
<SENT sid="9" pm="."><plain>Further studies showed that, compared with the control animals, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e>-CaBD decreased TUNEL (58%+/-7% versus 29%+/-3%, P&lt;0.05)- and cleaved caspase-3 (62+/-4/field versus 31+/-6/field, P&lt;0.05)-positive cells in the ischemic boundary zone </plain></SENT>
<SENT sid="10" pm="."><plain>These results indicate that systemic administration of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e>-CaBD could attenuate ischemic brain injury, suggesting that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PTD</z:e>-mediated protein transduction might provide a promising and effective approach for the therapies of <z:e sem="disease" ids="C0006111" disease_type="Disease or Syndrome" abbrv="">brain diseases</z:e>, including <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>